International expansion looks simple on paper: take what sells in one market and offer it in another. In practice, “the same product” behaves differently across countries because regulations, buyer expectations, logistics, and competitive baselines change what customers consider high quality and high value. That’s why the research stream on international product adaptation has remained relevant for decades […]
Author Archives: truemeds
Protein tyrosine kinases (PTKs) sit at the center of many cancer and immune signaling circuits. When PTK signaling is overactive through mutations, amplification, or pathway rewiring, cells can lock into growth and survival programs that are difficult to shut down. That is why protein tyrosine kinase inhibitors remain one of the most productive classes of targeted therapeutics, […]
Curcumin is one of the most widely studied natural compounds in oncology research. As a bright-yellow polyphenol from turmeric, it has been investigated across many tumor types for its ability to modulate survival, inflammation, invasion, and therapy response. What keeps curcumin interesting in 2026 is not the idea that it is a “single magic bullet,” but that […]
In modern small molecule drug discovery, the hardest part is often not finding a binder, but finding the right binder: a compound that engages the target with a useful binding mode, discriminates against closely related proteins, and remains developable. This is where DNA-Encoded Library (DEL) technology has changed expectations. By coupling chemical diversity to DNA barcodes, ultra-large libraries can […]
Ensuring the quality, safety, and efficacy of a pharmaceutical product is at the heart of pharmaceutical development. From early-stage research through commercial production, stability studies and testing play a central role in confirming that drug substances and drug products maintain their intended performance throughout their shelf life. In an era of diverse dosage forms, complex combination products, and innovative therapies, a structured stability […]
In the last few decades, ligand discovery has moved from “screen what you can physically test” to “explore chemical space at a scale that used to be impossible.” One of the most important steps in that journey is the rise of DNA-encoded chemical libraries often called DELs. By attaching a DNA barcode to each molecule, scientists gained […]
Antibiotics in Research have been foundational to modern medicine, transforming the treatment of infectious diseases and enabling advances in surgery, oncology, and immunotherapy. In this context, antibiotics are no longer viewed solely as therapeutic agents—they are also essential research tools. From probing bacterial physiology to validating drug targets, a diverse and well-characterized antibiotic portfolio plays […]
Atrial fibrillation (AFib) remains a major global health challenge, with current antiarrhythmic therapies often limited by toxicity and proarrhythmic risks. Vanoxerine, a novel multichannel antiarrhythmic, targets potassium (hERG), sodium, and calcium channels in a frequency-dependent manner, offering effective rhythm control while preserving uniform ventricular repolarization. Preclinical studies demonstrate potent multichannel blockade, minimal impact on QT […]
The Wnt/β-catenin signaling pathway is a fundamental regulator of cell proliferation, differentiation, and tissue homeostasis. Central to this pathway is the β-catenin destruction complex, a multiprotein assembly responsible for maintaining low cytoplasmic β-catenin levels in the absence of Wnt signals. Recent studies reveal that the scaffold protein Axin undergoes liquid–liquid phase separation (LLPS), forming dynamic […]
Rigosertib is an emerging anti-cancer agent that selectively targets rapidly dividing tumor cells by destabilizing microtubules, a critical component of the mitotic machinery. Recent studies using pharmaceutical-grade rigosertib confirm that its cytotoxic effects are intrinsic to the compound and not due to impurities or degradation products. Through chemical-genetic screens, biochemical assays, and structural studies, rigosertib’s […]